Unraveling the intricacies of neoadjuvant immune checkpoint blockade in esophageal squamous cell carcinoma: a comprehensive single-cell perspective.

Zou, Gengyi; Anwar, Junaid; Pizzi, Melissa P; Abdelhakeem, Ahmed

Zou, Gengyi; Anwar, Junaid; Pizzi, Melissa P; Abdelhakeem, Ahmed.

Afiliación

Zou G; Department of GI Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Anwar J; Department of Medicine, Baptist Hospitals of Southeast Texas, Beaumont, TX, USA.
Pizzi MP; Department of GI Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Abdelhakeem A; Department of Medicine, Baptist Hospitals of Southeast Texas, Beaumont, TX, USA.

J Thorac Dis ; 16(2): 826-828, 2024 Feb 29.

Article en En | MEDLINE | ID: mdl-38505072

Palabras clave

Esophageal squamous cell carcinoma (ESCC); neoadjuvant immune checkpoint blockade (neoadjuvant ICB); tumor microenvironment (TME)

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Thorac Dis Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google